Hidalgo-Filho, C. M., Gariazzo, E., Santo, V., Brunetti, L., Wang, X., Pecci, F., Ricciuti, B. (2026). Impact of
                    <i>STK11</i>
                    /
                    <i>KEAP1</i>
                    /
                    <i>SMARCA4</i>
                    co-mutations in RAS-activated
                    <i>KRAS</i>
                    wild-type metastatic NSCLC treated with immune checkpoint inhibitors.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.8565